{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:22Z","timestamp":1791214042579,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T00:00:00Z","timestamp":1395187200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0092171","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T02:54:44Z","timestamp":1395284084000},"page":"e92171","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Increased Levels of Eotaxin and MCP-1 in Juvenile Dermatomyositis Median 16.8 Years after Disease Onset; Associations with Disease Activity, Duration and Organ Damage"],"prefix":"10.1371","volume":"9","author":[{"given":"Helga","family":"Sanner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Flat\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vistnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivar","family":"Sjaastad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"A Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/rheumatology\/kep302","article-title":"Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset","volume":"48","author":"H Sanner","year":"2009","journal-title":"Rheumatology"},{"key":"ref3","first-page":"782","article-title":"Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients","volume":"28","author":"PR Mathiesen","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"ref4","unstructured":"Oppenheim JJ, Feldman M. (2001) Introduction to the role of cytokines in innate and defense and adaptive immunity. In: Oppenheim JJ FM, ed. Cytokine Reference.New York: Academic Press 3\u201320."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","article-title":"Role of cytokines and chemokines in idiopathic inflammatory myopathies","volume":"21","author":"PB De","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrrheum.2011.39","article-title":"Pathogenesis, classification and treatment of inflammatory myopathies","volume":"7","author":"M Zong","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/rheumatology\/keq196","article-title":"Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease","volume":"49","author":"T Gono","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00296-010-1692-y","article-title":"Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity","volume":"32","author":"P Mielnik","year":"2012","journal-title":"Rheumatol Int"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis","volume":"60","author":"H Bilgic","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","article-title":"The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis","volume":"72","author":"D Lazarevic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/ard.2010.137968","article-title":"Cardiac dysfunction in juvenile dermatomyositis: a case-control study","volume":"70","author":"T Schwartz","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/ard.2010.131433","article-title":"Pulmonary outcome in juvenile dermatomyositis: a case-control study","volume":"70","author":"H Sanner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"A Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acr.20203","article-title":"Long term muscular outcome, predisposing and prognostic factors in Juvenile Dermatomyositis: - A case control study","volume":"62","author":"H Sanner","year":"2010","journal-title":"Arthritis Care Res"},{"key":"ref15","unstructured":"Schwartz T, Sanner H, Gjesdal O, Flato B, Sjaastad I. (2013) In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity. Ann Rheum Dis; doi:10.1136\/annrheumdis-2013-."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.10924","article-title":"Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence","volume":"49","author":"RK Bode","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","article-title":"International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease","volume":"43","author":"DA Isenberg","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Sanner H, Sjaastad I, Flato B. (2014) The myositis disease activity assessment tool and the PRINTO criteria for clinically inactive disease applied after long-term follow-up in juvenile onset dermatomyositis. Rheumatology (Oxford): In Press.","DOI":"10.1093\/rheumatology\/keu146"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","article-title":"Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality","volume":"41","author":"SM Sultan","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"JF Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"ref21","first-page":"326","article-title":"Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire","volume":"22","author":"BM Feldman","year":"1995","journal-title":"J Rheumatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1152\/japplphysiol.01084.2009","article-title":"Circulating cytokine levels in mice with heart failure are etiology dependent","volume":"108","author":"M Vistnes","year":"2010","journal-title":"J Appl Physiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2006.03180.x","article-title":"Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies","volume":"146","author":"M Tucci","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)\u2014clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"LJ McCann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpeds.2005.10.032","article-title":"Duration of illness is an important variable for untreated children with juvenile dermatomyositis","volume":"148","author":"LM Pachman","year":"2006","journal-title":"J Pediatr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/rheumatology\/keq151","article-title":"Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand","volume":"49","author":"P Szodoray","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/ar3531","article-title":"Type I interferon pathway in adult and juvenile dermatomyositis","volume":"13","author":"EC Baechler","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/art.24555","article-title":"Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy","volume":"60","author":"TB Niewold","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1016\/j.transproceed.2010.05.152","article-title":"Eotaxin\/CCL11 levels correlate with myocardial fibrosis and mast cell density in native and transplanted rat hearts","volume":"42","author":"M Zweifel","year":"2010","journal-title":"Transplant Proc"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1440-1746.2006.04621.x","article-title":"Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course","volume":"22","author":"F Tacke","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0002-9440(10)61235-7","article-title":"Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis","volume":"167","author":"F Huaux","year":"2005","journal-title":"Am J Pathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"W de Jager","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","article-title":"Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis","volume":"62","author":"H Kokkonen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.cca.2010.07.006","article-title":"MCP-1: chemoattractant with a role beyond immunity: a review","volume":"411","author":"A Yadav","year":"2010","journal-title":"Clin Chim Acta"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm0496-449","article-title":"Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia","volume":"2","author":"EA Garcia-Zepeda","year":"1996","journal-title":"Nat Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"42957","DOI":"10.1074\/jbc.M103933200","article-title":"The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b","volume":"276","author":"R Martinelli","year":"2001","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/art.23591","article-title":"Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial","volume":"58","author":"CE Vergunst","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/jpet.105.097048","article-title":"A novel, selective, and orally available antagonist for CC chemokine receptor 3","volume":"317","author":"T Morokata","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/art.30106","article-title":"Ablation of the Ccr2 gene exacerbates polyarthritis in interleukin-1 receptor antagonist-deficient mice","volume":"63","author":"H Fujii","year":"2011","journal-title":"Arthritis Rheum"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0092171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T04:30:52Z","timestamp":1716611452000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0092171"}},"subtitle":[],"editor":[{"given":"Paul","family":"Proost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,19]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0092171","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,19]]}}}